NEW York & Presbyterian Hospitals, Inc. is a medicare approved dialysis facility center in New York, New York and it has 4 dialysis stations. It is located in New York county at 525 E 68th St, New York, NY, 10065. You can reach out to the office of NEW York & Presbyterian Hospitals, Inc. at (212) 746-5333. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. NEW York & Presbyterian Hospitals, Inc. has the following ownership type - Non-Profit. It was first certified by medicare in September, 1980. The medicare id for this facility is 330101 and it accepts patients under medicare ESRD program.
Name | NEW York & Presbyterian Hospitals, Inc. |
---|---|
Location | 525 E 68th St, New York, New York |
No. of Dialysis Stations | 4 |
Medicare ID | 330101 |
Managed By | Independent |
Ownership Type | Non-Profit |
Late Shifts | Yes |
525 E 68th St, New York, New York, 10065 | |
(212) 746-5333 | |
Not Available |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
Adoption of hourly rounds schedules for nurses working in acute care hospitals may improve patient safety and overall satisfaction with care provided, according to research reported in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
British patients will find new pharmacies easier to get to, open longer and offering a wider range of services locally following new rules to control the location of pharmacies Health Minister Rosie Winterton announced today.
› Verified 9 days ago
Dialysis patients with Hemoglobin data | 2 |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
Adoption of hourly rounds schedules for nurses working in acute care hospitals may improve patient safety and overall satisfaction with care provided, according to research reported in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
British patients will find new pharmacies easier to get to, open longer and offering a wider range of services locally following new rules to control the location of pharmacies Health Minister Rosie Winterton announced today.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 4 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 38 |
Percentage of adult patients getting regular hemodialysis at the center | |
Pediatic patients getting regular hemodialysis at the center | 3 |
Pediatric patient months included in in Kt/V greater than or eqaul to 1.2 | 18 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
Adoption of hourly rounds schedules for nurses working in acute care hospitals may improve patient safety and overall satisfaction with care provided, according to research reported in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
British patients will find new pharmacies easier to get to, open longer and offering a wider range of services locally following new rules to control the location of pharmacies Health Minister Rosie Winterton announced today.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at NEW York & Presbyterian Hospitals, Inc. with elevated calcium levels.
Patients with hypercalcemia | 8 |
Hypercalcemia patient months | 96 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
Patients with Serumphosphor | 5 |
Patients with Serumphosphor less than 3.5 mg/dL | |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
Patients with Serumphosphor from 5.6 to 7 mg/dL | |
Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
Adoption of hourly rounds schedules for nurses working in acute care hospitals may improve patient safety and overall satisfaction with care provided, according to research reported in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
British patients will find new pharmacies easier to get to, open longer and offering a wider range of services locally following new rules to control the location of pharmacies Health Minister Rosie Winterton announced today.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 5 |
Patient months included in arterial venous fistula and catheter summaries | 36 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
Adoption of hourly rounds schedules for nurses working in acute care hospitals may improve patient safety and overall satisfaction with care provided, according to research reported in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
British patients will find new pharmacies easier to get to, open longer and offering a wider range of services locally following new rules to control the location of pharmacies Health Minister Rosie Winterton announced today.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 4 |
Hospitalization Rate in facility | (Not Available) |
Hospitalization Rate: Upper Confidence Limit | |
Hospitalization Rate: Lower Confidence Limit |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the fourth quarter and full year ended Dec. 31, 2014.
Adoption of hourly rounds schedules for nurses working in acute care hospitals may improve patient safety and overall satisfaction with care provided, according to research reported in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality.
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
British patients will find new pharmacies easier to get to, open longer and offering a wider range of services locally following new rules to control the location of pharmacies Health Minister Rosie Winterton announced today.
› Verified 9 days ago